BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16023446)

  • 1. Gastrointestinal growth factors and neoplasia.
    Evers BM
    Am J Surg; 2005 Aug; 190(2):279-84. PubMed ID: 16023446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues.
    Thomas RP; Hellmich MR; Townsend CM; Evers BM
    Endocr Rev; 2003 Oct; 24(5):571-99. PubMed ID: 14570743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal hormones and cell proliferation.
    Townsend CM; Bold RJ; Ishizuka J
    Surg Today; 1994; 24(9):772-7. PubMed ID: 7865952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New approaches to early detection, estimation of prognosis and therapy for malignant tumours of the gastrointestinal tract].
    Röcken C; Neumann U; Ebert MP
    Z Gastroenterol; 2008 Feb; 46(2):216-22. PubMed ID: 18253902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Gab1 in pancreatic acinar cells: effects of gastrointestinal growth factors/hormones on stimulation, phosphospecific phosphorylation, translocation and interaction with downstream signaling molecules.
    Hoffmann KM; Tapia JA; Jensen RT
    Cell Signal; 2006 Jul; 18(7):942-54. PubMed ID: 16185843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
    Guillermet-Guibert J; Lahlou H; Pyronnet S; Bousquet C; Susini C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):535-51. PubMed ID: 16183526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin and growth of normal and neoplastic tissues.
    Evers BM
    Peptides; 2006 Oct; 27(10):2424-33. PubMed ID: 16904238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support.
    Bozzetti F; Gianotti L; Braga M; Di Carlo V; Mariani L
    Clin Nutr; 2007 Dec; 26(6):698-709. PubMed ID: 17683831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal hormone receptors in primary human colorectal carcinomas.
    Chao C; Tallman ML; Ives KL; Townsend CM; Hellmich MR
    J Surg Res; 2005 Dec; 129(2):313-21. PubMed ID: 16051276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells.
    Keramidas M; Faudot C; Cibiel A; Feige JJ; Thomas M
    J Endocrinol; 2008 Mar; 196(3):473-82. PubMed ID: 18310443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroenterological Cancer and Immunotherapy.
    Wang X; Yang YE; Jia L; Chen Q
    Can J Gastroenterol Hepatol; 2018; 2018():4697670. PubMed ID: 30073155
    [No Abstract]   [Full Text] [Related]  

  • 14. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of gastrointestinal tract malignancies.
    La Gamma N; Nandakumar G
    Hosp Pract (1995); 2013 Apr; 41(2):7-15. PubMed ID: 23545755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of gastrointestinal hormones in pancreatic cancer.
    Guo YS; Townsend CM
    J Hepatobiliary Pancreat Surg; 2000; 7(3):276-85. PubMed ID: 10982627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor-associated and epithelial markers in gastrointestinal tumors].
    Knuth A; Klingel R; Moll R; Dippold W; Meyer zum Büschenfelde KH
    Verh Dtsch Ges Inn Med; 1991; 97():414-9. PubMed ID: 1725565
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastrointestinal peptide signalling in health and disease.
    Rozengurt E; Guha S; Sinnett-Smith J
    Eur J Surg Suppl; 2002; (587):23-38. PubMed ID: 16144198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.